Nvidia-Backed iamb Therapeutics Files Nasdaq IPO Application on September 21
According to Bloomberg, on September 21, AI-driven drug development company iamb Therapeutics filed an IPO application with the U.S. Securities and Exchange Commission, seeking to list on Nasdaq Global Select Market under ticker symbol IAM. The company plans to use proceeds to advance development
NVDA-1.27%
GateNews·09-22 01:20
